Clarity Study - About Clarity Study

About the Study

Alzheimer’s disease can rob you of some of the best parts of your life.  In order to put up a proper fight against this condition, more clinical research is sorely needed and that’s where the Clarity AD Study comes in. The main goals of the study are to assess the safety and efficacy of an investigational drug for Alzheimer’s disease. 

The study will take place over the course of 24 months and consist of three phases: Screening, Treatment, and Follow Up. The study will enroll a total of 1566 participants.  Participants who complete 18 months of core treatment may be eligible to receive open-label treatment (where all participants will receive the investigational drug) for up to 2 years.

ctm-6

Interested in the Study?

Volunteering for a study, such as Clarity AD, is one major way you can help fight back against Alzheimer’s disease

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.